Literature DB >> 26490872

Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.

Mithilesh Kumar Jha1, Gyun Jee Song1, Maan Gee Lee1, Nam Ho Jeoung2, Younghoon Go3, Robert A Harris4, Dong Ho Park5, Hyun Kook6, In-Kyu Lee3, Kyoungho Suk7.   

Abstract

Pyruvate dehydrogenase kinases (PDK1-4) are mitochondrial metabolic regulators that serve as decision makers via modulation of pyruvate dehydrogenase (PDH) activity to convert pyruvate either aerobically to acetyl-CoA or anaerobically to lactate. Metabolic dysregulation and inflammatory processes are two sides of the same coin in several pathophysiological conditions. The lactic acid surge associated with the metabolic shift has been implicated in diverse painful states. In this study, we investigated the role of PDK-PDH-lactic acid axis in the pathogenesis of chronic inflammatory pain. Deficiency of Pdk2 and/or Pdk4 in mice attenuated complete Freund's adjuvant (CFA)-induced pain hypersensitivities. Likewise, Pdk2/4 deficiency attenuated the localized lactic acid surge along with hallmarks of peripheral and central inflammation following intraplantar administration of CFA. In vitro studies supported the role of PDK2/4 as promoters of classical proinflammatory activation of macrophages. Moreover, the pharmacological inhibition of PDKs or lactic acid production diminished CFA-induced inflammation and pain hypersensitivities. Thus, a PDK-PDH-lactic acid axis seems to mediate inflammation-driven chronic pain, establishing a connection between metabolism and inflammatory pain. SIGNIFICANCE STATEMENT: The mitochondrial pyruvate dehydrogenase (PDH) kinases (PDKs) and their substrate PDH orchestrate the conversion of pyruvate either aerobically to acetyl-CoA or anaerobically to lactate. Lactate, the predominant end product of glycolysis, has recently been identified as a signaling molecule for neuron-glia interactions and neuronal plasticity. Pathological metabolic shift and subsequent lactic acid production are thought to play an important role in diverse painful states; however, their contribution to inflammation-driven pain is still to be comprehended. Here, we report that the PDK-PDH-lactic acid axis constitutes a key component of inflammatory pain pathogenesis. Our findings establish an unanticipated link between metabolism and inflammatory pain. This study unlocks a previously ill-explored research avenue for the metabolic control of inflammatory pain pathogenesis.
Copyright © 2015 the authors 0270-6474/15/3514354-17$15.00/0.

Entities:  

Keywords:  PDK-PDH-lactic acid axis; chronic inflammatory pain; inflammation; macrophages; metabolism; pain

Mesh:

Substances:

Year:  2015        PMID: 26490872      PMCID: PMC6605420          DOI: 10.1523/JNEUROSCI.1910-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  97 in total

1.  Increased skin lactate in complex regional pain syndrome: evidence for tissue hypoxia?

Authors:  F Birklein; M Weber; B Neundörfer
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

Review 2.  Molecular mechanisms of nociception.

Authors:  D Julius; A I Basbaum
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

3.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 4.  The muscle in fibromyalgia.

Authors:  A Bengtsson
Journal:  Rheumatology (Oxford)       Date:  2002-07       Impact factor: 7.580

5.  Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood.

Authors:  P G Haji-Michael; L Ladrière; A Sener; J L Vincent; W J Malaisse
Journal:  Metabolism       Date:  1999-06       Impact factor: 8.694

6.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.

Authors:  Akinori Takaoka; Hideyuki Yanai; Seiji Kondo; Gordon Duncan; Hideo Negishi; Tatsuaki Mizutani; Shin-Ichi Kano; Kenya Honda; Yusuke Ohba; Tak W Mak; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-01-23       Impact factor: 49.962

7.  Blood supply and oxidative metabolism in muscle biopsies of female cleaners with and without myalgia.

Authors:  Britt Larsson; Jonas Björk; Fawzi Kadi; Rolf Lindman; Björn Gerdle
Journal:  Clin J Pain       Date:  2004 Nov-Dec       Impact factor: 3.442

8.  Effect of hyperoxia on vascular endothelial growth factor levels in a wound model.

Authors:  A Y Sheikh; J J Gibson; M D Rollins; H W Hopf; Z Hussain; T K Hunt
Journal:  Arch Surg       Date:  2000-11

9.  Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain.

Authors:  Hee Kee Kim; Soon Kwon Park; Jun-Li Zhou; Giulio Taglialatela; Kyungsoon Chung; Richard E Coggeshall; Jin Mo Chung
Journal:  Pain       Date:  2004-09       Impact factor: 6.961

Review 10.  Lactate metabolism: a new paradigm for the third millennium.

Authors:  L B Gladden
Journal:  J Physiol       Date:  2004-05-06       Impact factor: 5.182

View more
  19 in total

1.  Astrocytes in the Ventrolateral Preoptic Area Promote Sleep.

Authors:  Jae-Hong Kim; In-Sun Choi; Ji-Young Jeong; Il-Sung Jang; Maan-Gee Lee; Kyoungho Suk
Journal:  J Neurosci       Date:  2020-10-16       Impact factor: 6.167

2.  The related mechanism of complete Freund's adjuvant-induced chronic inflammation pain based on metabolomics analysis.

Authors:  Weibo Zhang; Jie Lyu; Juxiang Xu; Piao Zhang; Shuxia Zhang; Yeru Chen; Yongjie Wang; Gang Chen
Journal:  Biomed Chromatogr       Date:  2021-01-28       Impact factor: 1.902

3.  Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.

Authors:  Caroline Guglielmetti; Chloé Najac; Alessandro Didonna; Annemie Van der Linden; Sabrina M Ronen; Myriam M Chaumeil
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

4.  Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease.

Authors:  Mingshan Xue; Yifeng Zeng; Runpei Lin; Hui-Qi Qu; Teng Zhang; Xiaohua Douglas Zhang; Yueting Liang; Yingjie Zhen; Hao Chen; Zhifeng Huang; Haisheng Hu; Peiyan Zheng; Hakon Hakonarson; Luqian Zhou; Baoqing Sun
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-06

Review 5.  Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases.

Authors:  Gyun Jee Song; Kyoungho Suk
Journal:  Front Aging Neurosci       Date:  2017-05-15       Impact factor: 5.750

6.  In vivo metabolic imaging of Traumatic Brain Injury.

Authors:  Caroline Guglielmetti; Austin Chou; Karen Krukowski; Chloe Najac; Xi Feng; Lara-Kirstie Riparip; Susanna Rosi; Myriam M Chaumeil
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

Review 7.  The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain.

Authors:  Anna Ronowska; Andrzej Szutowicz; Hanna Bielarczyk; Sylwia Gul-Hinc; Joanna Klimaszewska-Łata; Aleksandra Dyś; Marlena Zyśk; Agnieszka Jankowska-Kulawy
Journal:  Front Cell Neurosci       Date:  2018-07-10       Impact factor: 5.505

8.  Metabolic disturbances in synovial fluid are involved in the onset of synovitis in heifers with acute ruminal acidosis.

Authors:  Pablo Alarcon; Alejandra I Hidalgo; Carolina Manosalva; Raul Cristi; Stefanie Teuber; Maria A Hidalgo; Rafael A Burgos
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

9.  PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord.

Authors:  Binbin Wang; Siyuan Liu; Bingbing Fan; Xingguo Xu; Yonglin Chen; Rongxiang Lu; Zhongling Xu; Xiaojuan Liu
Journal:  J Headache Pain       Date:  2018-01-18       Impact factor: 7.277

10.  VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism.

Authors:  Jialin Li; Bo Diao; Sheng Guo; Xiaoyong Huang; Chengying Yang; Zeqing Feng; Weiming Yan; Qin Ning; Lixin Zheng; Yongwen Chen; Yuzhang Wu
Journal:  Nat Commun       Date:  2017-11-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.